STOCK TITAN

Robert Barrow files to sell 24,431 DFTX shares (DFTX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Robert Barrow filed a Form 144 reporting an intended sale of 24,431 shares of Common stock of DFTX on 03/25/2026, described as restricted stock vesting under a registered plan. The filing also shows a prior sale of 25,791 shares on 12/26/2025.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 for vested restricted shares; compliance disclosure, not a company action.

The filing lists an intended disposition of 24,431 shares tied to restricted stock vesting under a registered plan, with the broker listed as Morgan Stanley Smith Barney LLC. This is a disclosure required when restricted shares become eligible for sale.

Timing and cash‑flow treatment are those stated: the sale date is 03/25/2026. Prior reported sales include 25,791 shares sold on 12/26/2025. Subsequent filings will show execution details and any Rule 144 reliance.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Robert Barrow's Form 144 for DFTX report?

It reports an intended sale of 24,431 shares of DFTX common stock on 03/25/2026. The sale is described as restricted stock vesting under a registered plan, with a prior sale of 25,791 shares on 12/26/2025.

Does the Form 144 indicate how proceeds will be used?

No. The filing states the securities are being sold due to restricted stock vesting under a registered plan. It does not specify use of proceeds or purchaser details in the provided excerpt.

Who is the broker or intermediary listed on the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor. The filing ties the proposed sale to that broker for the stated sale date of 03/25/2026.

Were there recent prior sales reported by the same filer?

Yes. The filing shows prior sales of 25,791 shares on 12/26/2025. That prior sale amount is reported in the "Securities Sold During The Past 3 Months" section of the excerpt.
Mind Medicine

NASDAQ:MNMD

View MNMD Stock Overview

MNMD Rankings

MNMD Latest News

MNMD Latest SEC Filings

MNMD Stock Data

1.48B
97.40M
Biotechnology
Medicinal Chemicals & Botanical Products
Link
United States
NEW YORK